Trial intelligence / Profile preview

Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

NCT05700916Phase 1Active, not recruiting

Sponsor
University of Connecticut
Start
Oct 2023
Primary completion
Dec 2026
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in dyslipidemia and obesity (2 arms), sponsored by University of Connecticut. Primary endpoint: Serum LDL Cholesterol at 8 weeks. Started Oct 2023; status: active, not recruiting.

02

Conditions

dyslipidemiaobesity

Beyond the preview

Go deeper on NCT05700916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05700916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call